HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel beta-endorphin binding protein. Complement S protein (= vitronectin) exhibits specific non-opioid binding sites for beta-endorphin upon interaction with heparin or surfaces.

Abstract
Human beta-endorphin (1-31) (beta H-endorphin) was found to specifically interact with purified complement S protein from human plasma. As found by chemical cross-linking beta H-endorphin bound to both, the 65- and 75-kDa molecular mass forms of S protein. The interaction of S protein with heparin as well as the adsorption of S protein to surfaces led to an almost 10-fold increase of specific binding which was due to the exposure of further beta H-endorphin-binding sites. The interaction of beta H-endorphin with S protein bore characteristics of a ligand-receptor interaction, such as time dependence, reversibility, high affinity, saturability, and structural specificity and was mediated through the non-opioid COOH terminus of the beta H-endorphin molecule. beta H-Endorphin binding to S protein was observed at physiological pH or cation concentrations, indicating that the interaction may well occur in vivo. Our results provide conclusive evidence that interactions of S protein with very different effectors led to similar conformational changes which uniformly resulted in exposure of a highly specific beta H-endorphin binding domain on S protein. With S protein as major beta H-endorphin-binding protein in the periphery, the molecular basis of a widespread system of humoral target sites of the neuroendocrine effector appears to be established. In view of S protein involvement in processes of inflammation and wound repair and beta-endorphin effects on immunocompetent cells, the demonstrated S protein-beta H-endorphin interaction appears to be of considerable functional significance.
AuthorsA Hildebrand, K T Preissner, G Müller-Berghaus, H Teschemacher
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 264 Issue 26 Pg. 15429-34 (Sep 15 1989) ISSN: 0021-9258 [Print] United States
PMID2475499 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Proteins
  • Cross-Linking Reagents
  • Glycoproteins
  • Glycosaminoglycans
  • Peptide Fragments
  • Succinimides
  • Vitronectin
  • beta-Endorphin
  • Heparin
  • disuccinimidyl suberate
Topics
  • Binding Sites
  • Blood Proteins (metabolism)
  • Cross-Linking Reagents (pharmacology)
  • Glycoproteins (isolation & purification, metabolism)
  • Glycosaminoglycans (pharmacology)
  • Heparin (pharmacology)
  • Humans
  • Kinetics
  • Molecular Weight
  • Peptide Fragments (metabolism)
  • Succinimides (pharmacology)
  • Vitronectin
  • beta-Endorphin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: